Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor. According to our (Global Info Research) latest study, the global Sacral Nerve Stimulation market size was valued at USD 764.1 million in 2022 and is forecast to a readjusted size of USD 1539.7 million by 2029 with a CAGR of 10.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years. This report is a detailed and comprehensive analysis for global Sacral Nerve Stimulation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Sacral Nerve Stimulation market size and forecasts, in consumption value ($ Million), 2018-2029 Global Sacral Nerve Stimulation market size and forecasts by region and country, in consumption value ($ Million), 2018-2029 Global Sacral Nerve Stimulation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029 Global Sacral Nerve Stimulation market shares of main players, in revenue ($ Million), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Sacral Nerve Stimulation To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Sacral Nerve Stimulation market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Abbott, Axonics Modulation Technologies and Nuvectra, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market segmentation Sacral Nerve Stimulation market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Implantable SNS External SNS Market segment by Application Hospitals Clinics ASCs Market segment by players, this report covers Medtronic Boston Scientific Abbott Axonics Modulation Technologies Nuvectra Cogentix Medical Cyberonics Uroplasty, Inc Neuropace IntraPace, Inc Codman & Shurtleff, Inc Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific) South America (Brazil, Argentina and Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa) The content of the study subjects, includes a total of 13 chapters: Chapter 1, to describe Sacral Nerve Stimulation product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top players of Sacral Nerve Stimulation, with revenue, gross margin and global market share of Sacral Nerve Stimulation from 2018 to 2023. Chapter 3, the Sacral Nerve Stimulation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast. Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029. Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Sacral Nerve Stimulation market forecast, by regions, type and application, with consumption value, from 2024 to 2029. Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War Chapter 12, the key raw materials and key suppliers, and industry chain of Sacral Nerve Stimulation. Chapter 13, to describe Sacral Nerve Stimulation research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Sacral Nerve Stimulation 1.2 Market Estimation Caveats and Base Year 1.3 Classification of Sacral Nerve Stimulation by Type 1.3.1 Overview: Global Sacral Nerve Stimulation Market Size by Type: 2018 Versus 2022 Versus 2029 1.3.2 Global Sacral Nerve Stimulation Consumption Value Market Share by Type in 2022 1.3.3
